Patricia Inácio, PhD, science writer —

The lack of a reflex response that was relieved temporarily after exercise, a phenomenon known as post-exercise facilitation, is an early sign of Lambert-Eaton myasthenic syndrome (LEMS), a case report suggests. The report described the case of a woman, 62, who had a neuroendocrine tumor in the gallbladder…

A 40-year-old man who developed Lambert-Eaton myasthenic syndrome (LEMS) secondary to a cancer of the lymphatic system saw his LEMS symptoms ease only after he received comprehensive treatment involving several medical specialties, according to a case report. The patient, who had a type of B-cell lymphoma, developed weakness…

A case of Lambert-Eaton myasthenic syndrome (LEMS) was identified in an older man who was initially hospitalized with a wrongful diagnosis of aspiration pneumonia. He was later diagnosed with small cell lung cancer (SCLC), an aggressive form of lung cancer that is often associated with LEMS, but was too…

A possible first case of a man with non-small cell lung cancer (NSCLC) developing Lambert-Eaton myasthenic syndrome (LEMS) after being treated with Tecentriq (atezolizumab) has been reported in Pennsylvania. This case adds to prior evidence linking the use of Tecentriq, as well as the immunotherapies Opdivo and…

A total of 30 patient advocacy groups working to further understanding and the needs of people living with rare diseases have been selected to receive a Horizon Therapeutics‘ #RAREis Global Advocate Grant. Winners of this year’s inaugural awards are spread across nine countries and represent a total of 29 rare…

Sessions advocating for increased access to treatment for rare diseases, and the need for greater equity, were some of the featured highlights of the NORD “Living Rare, Living Stronger Patient and Family Forum.” Other key takeaways from the forum — hosted by the National Organization for Rare Disorders, known…

Lawmakers in Connecticut agreed to set up a permanent Rare Disease Advisory Council (RDAC), an advisory body working to better address the unique needs of people with rare diseases like Lambert-Eaton myasthenic syndrome (LEMS). An effort to establish these councils across the U.S. and to optimize existing ones,…

The case of an 8-year-old girl with Lambert-Eaton myasthenic syndrome (LEMS) who had no signs of a tumor, but had progressive muscle weakness, shows the need for comprehensive analysis and thorough investigation to prevent treatment delays. The report, “Lambert-Eaton myasthenic syndrome in a young girl,” was published in…

A simple, noninvasive test on the skin, called skin sympathetic response, can be used to confirm impairments in the autonomic nervous system — the non-conscious part of the nervous system that controls several bodily functions — in people with Lambert-Eaton myasthenic syndrome (LEMS), according to a case study. The…

Catalyst Pharmaceuticals kicked off this year’s Rare Disease Day, along with rare disease advocacy partners, with a virtual opening bell ceremony at the Nasdaq stock market. “Catalyst Pharmaceuticals and our dedicated team of employees, patients, and numerous patient advocacy groups are thrilled to be here at Nasdaq today for…